Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

107

Enrollment

OTHER

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer
Triple Negative Breast Cancer
NSCLC
NSCLC Stage IV
Non Small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
NSCLC Stage IV Without EGFR/ALK Mutation

Interventions

RADIATION: Sterotactic Body Radiotherapy/SBRT
DRUG: Standard of care

Sponsor

Memorial Sloan Kettering Cancer Center